CYRX · Cryoport, Inc. · Financials
Market Cap
$803.55M
Shares
50.65M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$176.18M
+12.4%
FY2025
Net Income
$78.3M
+168.2%
FY2025
Gross Margin
47.14%
+2.7pp
FY2025
Operating Margin
-20.89%
+56.7pp
FY2025
Diluted EPS
$1.40
+156.2%
FY2025
Operating Cash Flow
-$8.58M
+47.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $192M – $196M | $186.45M | $176.18M | $156.77M | $168.66M | $237.28M | $222.61M | $78.7M | $33.94M | $19.63M | $11.95M | $7.68M | $3.94M | $2.66M | $1.1M | $555.64K | |
| — | $98.68M | $93.12M | $87.11M | $93.33M | $133.4M | $126.03M | $42.36M | $16.59M | $9.39M | $5.99M | $4.58M | $2.77M | $2.22M | $1.59M | $1.39M | |
| — | $87.77M | $83.05M | $69.66M | $75.33M | $103.87M | $96.58M | $36.33M | $17.35M | $10.24M | $5.97M | $3.1M | $1.17M | $436.96K | -$487.28K | -$836.82K | |
| — | — | 47.14% | 44.43% | 44.67% | 43.78% | 43.38% | 46.17% | 51.12% | 52.18% | 49.91% | 40.39% | 29.7% | 16.43% | -44.28% | -150.61% | |
| — | $17.75M | $17.04M | $17.71M | $18.04M | $15.72M | $16.84M | $9.48M | $3.74M | $1.84M | $1.21M | $598.11K | $352.58K | $409.11K | $425.45K | $491.85K | |
| — | $12.66M | — | — | — | — | — | — | $13.82M | $7.25M | $5.23M | $4.82M | — | — | — | — | |
| — | $22.69M | — | — | — | — | — | — | $17.47M | $9.8M | $7.42M | $6.45M | — | — | — | — | |
| — | $109.64M | $102.82M | $109.81M | $108.26M | $120.06M | $97.56M | $56.86M | $31.29M | — | — | — | $6.41M | $5.11M | $5.41M | $6.11M | |
| — | $13M | $12.7M | $12.5M | $12.2M | $15.1M | $14.4M | $6.6M | $300K | $0 | $0 | $30.1K | $43.2K | $92.2K | $112.26K | — | |
| — | $25.76M | $27.71M | $30.76M | $27.49M | $22.77M | $20.25M | $9.87M | $2.42M | $857.94K | $664.83K | $374.2K | $197.94K | $311.59K | $393.96K | $343.03K | |
| — | $127.39M | $119.86M | $191.33M | $175.87M | $135.78M | $114.41M | $66.34M | $35.03M | $18.88M | $13.86M | $11.87M | $6.76M | $5.52M | $5.84M | $6.6M | |
| — | -$39.62M | -$36.81M | -$121.67M | -$100.54M | -$31.9M | -$17.83M | -$30.01M | -$17.68M | -$8.64M | -$7.89M | -$8.77M | -$5.59M | -$5.08M | -$6.32M | -$7.43M | |
| — | — | -20.89% | -77.61% | -59.61% | -13.45% | -8.01% | -38.13% | -52.07% | -44.05% | -66.02% | -114.16% | -142.12% | -190.92% | -574.67% | -1338.05% | |
| — | -$13.86M | -$9.09M | -$90.91M | -$73.05M | -$9.14M | $2.42M | -$20.14M | -$15.26M | -$7.79M | -$7.23M | -$8.39M | -$5.4M | -$4.77M | -$5.93M | -$7.09M | |
| — | $2.11M | $2.36M | $3.98M | $5.5M | $6.14M | $4.69M | $2.56M | $1.37M | $69.25K | $15.69K | $139.42K | $1.43M | $784.45K | $72.86K | $527.75K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $11.94K | |
| — | $8.62M | $4.64M | $17.32M | $16.32M | -$3.19M | -$256.01M | -$2.73M | -$595K | -$891.03K | -$1356 | -$4.34M | -$4266 | -$8078 | -$56.38K | -$396.65K | |
| — | -$31M | -$32.17M | -$104.35M | -$84.21M | -$35.09M | -$273.84M | -$32.74M | -$18.27M | -$9.54M | -$7.89M | -$13.11M | -$7.03M | -$19.56M | -$6.38M | -$7.83M | |
| — | $1.9M | $1.8M | $359K | $345K | $2.24M | $1.69M | -$45K | $62K | $19.95K | $5143 | $5673 | $1600 | $1600 | $1600 | $1600 | |
| — | -$37.39M | $78.3M | -$114.76M | -$99.59M | -$37.33M | -$275.53M | -$32.69M | -$18.33M | -$9.56M | -$7.9M | -$13.11M | -$7.03M | -$19.57M | -$6.38M | -$7.83M | |
| — | — | 44.44% | -73.2% | -59.05% | -15.73% | -123.77% | -41.54% | -54.01% | -48.69% | -66.08% | -170.77% | -178.56% | -735.56% | -579.94% | -1409.72% | |
| — | -$45.39M | $70.3M | -$122.76M | -$107.59M | -$45.33M | -$283.72M | -$75.03M | -$18.33M | — | -$7.9M | -$13.19M | -$12.2M | -$19.57M | — | — | |
| — | -$34.44M | $95.75M | -$109.62M | -$91.1M | -$70.64M | -$282.15M | -$27.27M | -$18.38M | -$9.55M | -$7.9M | — | — | — | — | — | |
| USD/shares | — | -$0.90 | $1.40 | -$2.49 | -$2.21 | -$0.93 | -$6.18 | -$1.94 | -$0.55 | — | — | — | — | — | — | — |
| USD/shares | — | -$0.90 | $1.40 | -$2.49 | -$2.21 | -$0.93 | -$6.18 | -$1.94 | -$0.55 | — | — | — | — | — | — | — |
| shares | — | — | 50.07M | 49.35M | 48.74M | 48.99M | 45.93M | 38.58M | 33.39M | 28.21M | 22.96M | 14.22M | 5.01M | 48.85M | 37.76M | 28.97M |
| shares | — | — | 50.07M | 49.35M | 48.74M | 48.99M | 45.93M | 38.58M | 33.39M | 28.21M | 22.96M | 14.22M | 5.01M | 48.85M | 38.17M | 28.97M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: $47.97M in buybacks.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 0.99×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 8 similar-size Integrated Freight & Logistics companies (of 30 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Life Sciences Services | $101,028,000 | $85,335,000 | $81,188,000 | — | — | — | — |
| Life Sciences Products | $75,149,000 | $71,434,000 | $87,474,000 | — | — | — | — |
| Global Logistics Solutions | — | — | — | — | $222,608,000 | $78,696,000 | $33,942,000 |
| Life Science Supply Chain Solutions Segment | — | $156,951,000 | $145,781,000 | $135,179,000 | — | — | — |
| Life Science Systems Segment | — | $71,434,000 | $87,474,000 | $102,098,000 | — | — | — |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Americas | $131,260,000 | $113,545,000 | $117,895,000 | $128,209,000 | $120,270,000 | $49,555,000 | $28,801,000 |
| EMEA | $25,134,000 | $27,022,000 | $27,650,000 | $66,913,000 | $59,334,000 | $20,316,000 | $4,523,000 |
| Asia Pacific | $19,783,000 | $16,202,000 | $23,117,000 | $42,155,000 | $43,004,000 | $8,825,000 | $618,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Service | $96,497,000 | $82,044,000 | $79,494,000 | $133,879,000 | — | $55,299,000 | $33,942,000 |
| Product | $79,680,000 | $74,725,000 | $89,168,000 | $103,398,000 | — | $23,397,000 | — |
| Biologistics Solutions | $78,137,000 | $67,019,000 | $65,905,000 | $124,798,000 | — | — | — |
| Biostorage Bioservices | $18,360,000 | $15,025,000 | $13,589,000 | $9,081,000 | — | — | — |
| Animal Health | — | — | $30,379,000 | $33,465,000 | $33,353,000 | — | — |
| Biopharmaceutical | — | — | $192,583,000 | $193,879,000 | $180,203,000 | — | — |
| Reproductive Medicine | — | — | $10,293,000 | $9,933,000 | $9,052,000 | — | — |